C85.91 Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck

Name of the Condition

• Common Name: Non-Hodgkin Lymphoma
• Medical Term: Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck
• ICD Code: C85.91

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that affect the lymphatic system, part of the immune system. This code is used when the specific subtype of NHL is not clearly defined and the lymphoma is located in the lymph nodes of the head, face, or neck. The lymphatic system helps fight infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes in the head, face, or neck
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Persistent cough or chest discomfort
• Itching or skin rashes
• Difficulty swallowing or breathing (if lymph nodes press on nearby structures)

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI scans), and a biopsy of the affected lymph node. Blood tests and bone marrow evaluation may also be performed to assess the extent of the disease and rule out other conditions.

Treatment Options

• Chemotherapy: Uses drugs to destroy cancer cells, often the primary treatment for NHL.
• Radiation therapy: Targets localized lymphoma in the head, face, or neck area.
• Immunotherapy: Enhances the immune system to fight cancer cells.
• Targeted therapy: Uses drugs to target specific cancer cell characteristics.
• Stem cell transplant: May be considered for aggressive or recurrent cases.

Prognosis and Follow-Up

Prognosis depends on factors such as the subtype, stage, and overall health. Regular follow-up appointments, including imaging and blood tests, are essential to monitor for recurrence or progression. Early detection and treatment improve outcomes.

Complications

• Spread of cancer to other organs or lymph nodes
• Infection due to weakened immune system
• Anemia or low blood cell counts
• Lymphedema (swelling) in the head, face, or neck
• Organ dysfunction if lymphoma affects nearby structures

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid exposure to known carcinogens, such as certain chemicals or radiation.
• Manage chronic infections or immune disorders with medical care.
• Limit alcohol consumption and avoid smoking.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or other symptoms listed above. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use code C85.91 when documenting non-Hodgkin lymphoma of unspecified subtype located in the lymph nodes of the head, face, or neck. Ensure the medical record specifies the anatomical site and lack of subtype detail to support this code. Verify that the diagnosis aligns with clinical findings and avoid using this code if a more specific subtype or site is documented.